On the public citation graph

A simple method for the quantification of 140 s particles of foot-and-mouth disease virus (FMDV)

https://doi.org/10.1007/bf01242879
0 signed · 96 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/bf01242904openalex-snapshot
A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure
inferredcites →https://doi.org/10.1007/bf01249678openalex-snapshot
The use of frozen cells in the agar-cell suspension titration technique
inferredcites →https://doi.org/10.1007/bf01258364openalex-snapshot
Immunochemical studies of foot-and-mouth disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4657879openalex-extracted
inferred← citeshttps://doi.org/10.1002/elsc.202000033openalex-snapshot
Characterization and stabilization in process development and product formulation for super large proteinaceous particles
inferred← citeshttps://doi.org/10.1007/bf01310652openalex-snapshot
Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine
inferred← citeshttps://doi.org/10.1007/bf01317896openalex-snapshot
Stability and immunogenicity of empty particles of foot-and-mouth disease virus
inferred← citeshttps://doi.org/10.1007/bf01317933openalex-snapshot
Localisation on foot-and-mouth disease virus (FMDV) of an antigenic deficiency induced by passage in BHK cells
inferred← citeshttps://doi.org/10.1007/bf01320790openalex-snapshot
Thermal stability of foot-and-mouth disease virus
inferred← citeshttps://doi.org/10.1007/bf02787811openalex-snapshot
Foot and mouth disease virus concentration and purification by affinity chromatography
inferred← citeshttps://doi.org/10.1007/bfb0000677openalex-snapshot
The use of BHK suspension cells for the production of foot and mouth disease vaccines
inferred← citeshttps://doi.org/10.1007/s00705-022-05624-2openalex-snapshot
Assessment of the potency and effectiveness of a heptavalent oil-adjuvanted (ISA 206) foot-and-mouth disease vaccine in Egypt
inferred← citeshttps://doi.org/10.1016/0166-0934(94)90184-8openalex-snapshot
Quantification of adenovirus particles
inferred← citeshttps://doi.org/10.1016/0264-410x(94)90055-8openalex-snapshot
Immunogenicity of foot-and-mouth disease virus grown in BHK-21 suspensioncells. Correlation with cell ploidy alterations and abnormal expression of the α5β1 integrin
inferred← citeshttps://doi.org/10.1016/0378-1135(76)90011-0openalex-snapshot
Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines
inferred← citeshttps://doi.org/10.1016/1045-1056(90)90036-yopenalex-snapshot
Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104920openalex-snapshot
Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage
inferred← citeshttps://doi.org/10.1016/j.bej.2017.05.004openalex-snapshot
Denaturation of inactivated FMDV in ion exchange chromatography: Evidence by differential scanning calorimetry analysis
inferred← citeshttps://doi.org/10.1016/j.biologicals.2015.01.002openalex-snapshot
A simple method for measuring porcine circovirus 2 whole virion particles and standardizing vaccine formulation
inferred← citeshttps://doi.org/10.1016/j.chroma.2020.461834openalex-snapshot
On-line separation and quantification of virus antigens of different serotypes in multivalent vaccines by capillary zone electrophoresis: A case study for quality control of foot-and-mouth disease virus vaccines
inferred← citeshttps://doi.org/10.1016/j.jviromet.2019.04.009openalex-snapshot
Determination of the optimal method for the concentration and purification of 146S particles for foot-and-mouth disease vaccine production
inferred← citeshttps://doi.org/10.1016/j.pep.2015.04.011openalex-snapshot
A hydrophobic interaction chromatography strategy for purification of inactivated foot-and-mouth disease virus
inferred← citeshttps://doi.org/10.1016/j.vaccine.2008.04.062openalex-snapshot
Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.01.069openalex-snapshot
Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.05.078openalex-snapshot
Foot and mouth disease (FMD) virus: Quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.09.011openalex-snapshot
Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.01.031openalex-snapshot
Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.03.066openalex-snapshot
Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.09.055openalex-snapshot
Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.03.037openalex-snapshot
Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry
inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.04.078openalex-snapshot
Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus
inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.07.051openalex-snapshot
Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing
inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.07.102openalex-snapshot
Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.06.033openalex-snapshot
An IgG1 single-dilution avidity ELISA predicts cross-protection against heterologous foot-and-mouth disease virus challenge after vaccination
inferred← citeshttps://doi.org/10.1016/j.vaccine.2025.126845openalex-snapshot
Foot-and-mouth disease vaccine quality: A universal test for intact viral capsids based on detection of VP4
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128958openalex-snapshot
Adjuvant properties of baculovirus enhance the immunogenicity and protective efficacy of foot-and-mouth disease virus-like particles vaccines in mice
inferred← citeshttps://doi.org/10.1016/j.vetmic.2017.08.014openalex-snapshot
Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine
inferred← citeshttps://doi.org/10.1016/j.virol.2014.11.023openalex-snapshot
Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles
inferred← citeshttps://doi.org/10.1016/j.virusres.2015.06.008openalex-snapshot
Recovery of infectious type Asia1 foot-and-mouth disease virus from suckling mice directly inoculated with an RNA polymerase I/II-driven unidirectional transcription plasmid
inferred← citeshttps://doi.org/10.1016/s0007-1935(17)33593-5openalex-snapshot
Factors Affecting the Quality of Foot and Mouth Disease Vaccines
inferred← citeshttps://doi.org/10.1016/s0034-5288(18)30539-3openalex-snapshot
Foot-and-mouth disease vaccination: a multifactorial study of the influence of antigen dose and potentially competitive immunogens on the response of cattle of different ages
inferred← citeshttps://doi.org/10.1016/s0092-1157(82)80028-0openalex-snapshot
Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines
inferred← citeshttps://doi.org/10.1016/s0092-1157(83)80018-3openalex-snapshot
Innocuity testing of foot-and-mouth disease vaccines I. Formaldeyde-inactivated alhydrogel vaccines
inferred← citeshttps://doi.org/10.1016/s0092-1157(83)80019-5openalex-snapshot
Innocuity testing of foot-and-mouth disease vaccines II. Aziridine-inactivated antigen produced in baby hamster kidney cells
inferred← citeshttps://doi.org/10.1016/s0092-1157(84)80025-6openalex-snapshot
The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats
inferred← citeshttps://doi.org/10.1016/s0092-1157(84)80027-xopenalex-snapshot
The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle
inferred← citeshttps://doi.org/10.1016/s0092-1157(84)80059-1openalex-snapshot
An indirect sandwich enzyme labelled immunosorbent assay for the detection of foot and mouth disease virus immunizing antigen in tissue culture harvests
inferred← citeshttps://doi.org/10.1016/s0092-1157(85)80048-2openalex-snapshot
An international collaborative study on foot and mouth disease virus assay methods. 2. Quantification of 146S particles
inferred← citeshttps://doi.org/10.1016/s2095-3119(18)61916-1openalex-snapshot
Insertion site of FLAG on foot-and-mouth disease virus VP1 G-H loop affects immunogenicity of FLAG
inferred← citeshttps://doi.org/10.1080/01652176.1987.9694134openalex-snapshot
Foot‐and‐mouth disease vaccine production and research in the Netherlands
inferred← citeshttps://doi.org/10.1080/09712119.2017.1335641openalex-snapshot
Alternatives for the serological assessment of foot-and-mouth disease vaccine immunity in buffaloes (Bubalus bubalis)
inferred← citeshttps://doi.org/10.1111/j.1439-0450.1977.tb01001.xopenalex-snapshot
Wirksamkeitsbestimmung von MKS‐Vaccinen im 3‐Punkte‐Test an Mäusen
inferred← citeshttps://doi.org/10.1111/j.1439-0450.1979.tb00798.xopenalex-snapshot
The Challenge of Vaccinated Pigs with Foot-and-Mouth Disease Virus
inferred← citeshttps://doi.org/10.1111/j.1439-0450.1991.tb00919.xopenalex-snapshot
Hämorrhagische Septikämie der Kaninchen (Rabbit Haemorrhagic Disease, RHD) ‐ Untersuchungen zum quantitativen Antigennachweis
inferred← citeshttps://doi.org/10.1111/jam.14465openalex-snapshot
Comparison of chemical extraction methods for determination of 146S content in foot‐and‐mouth disease oil‐adjuvanted vaccine
inferred← citeshttps://doi.org/10.1111/jam.15024openalex-snapshot
Investigation of the optimal medium and application strategy for foot‐and‐mouth disease vaccine antigen production
inferred← citeshttps://doi.org/10.1128/jvi.02879-12openalex-snapshot
Early Adaptive Immune Responses in the Respiratory Tract of Foot-and-Mouth Disease Virus-Infected Cattle
inferred← citeshttps://doi.org/10.1201/9780429125614-11openalex-snapshot
Modern Inactivated Foot-and-Mouth Disease (FMD) Vaccines: Historical Background and Key Elements in Production and Use
inferred← citeshttps://doi.org/10.1201/9781420037968.ch11openalex-snapshot
Modern Inactivated Foot-and-Mouth Disease (FMD) Vaccines
inferred← citeshttps://doi.org/10.1371/journal.pone.0149569openalex-snapshot
Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves
inferred← citeshttps://doi.org/10.1371/journal.pone.0232782openalex-snapshot
The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine
inferred← citeshttps://doi.org/10.1371/journal.pone.0353701openalex-snapshot
Comprehensive evaluation of an emergency monovalent SAT1 foot-and-mouth-disease vaccine: Antigen quality, product consistency, and protective efficacy
inferred← citeshttps://doi.org/10.20506/rst.15.3.954openalex-snapshot
The performance of Southern African Territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines
inferred← citeshttps://doi.org/10.20506/rst.3.2.162openalex-snapshot
Inactivation, purification and stability of 146S antigens of foot and mouth disease virus for use as reagents in the complement fixation test
inferred← citeshttps://doi.org/10.20506/rst.8.3.425openalex-snapshot
Effect of formaldehyde and binary ethyleneimine (BEI) on the integrity of foot and mouth disease virus capsid
inferred← citeshttps://doi.org/10.21608/bvmj.2015.31855openalex-snapshot
Correlation between foot-and-mouth disease virus antigenic mass, titer and immune response in vaccinated sheep
inferred← citeshttps://doi.org/10.3109/10837450.2013.763263openalex-snapshot
Chitosan-based systems for intranasal immunization against foot-and-mouth disease
inferred← citeshttps://doi.org/10.3389/fcimb.2026.1760751openalex-snapshot
Bioinformatics based design of thermostable virus-like particles-based vaccine for foot-and-mouth disease serotype A and in-vivo evaluation in guinea pigs
inferred← citeshttps://doi.org/10.3389/fimmu.2017.00960openalex-snapshot
Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control
inferred← citeshttps://doi.org/10.3389/fvets.2016.00052openalex-snapshot
Proper Timing of Foot-and-Mouth Disease Vaccination of Piglets with Maternally Derived Antibodies Will Maximize Expected Protection Levels
inferred← citeshttps://doi.org/10.3389/fvets.2020.554305openalex-snapshot
Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency
inferred← citeshttps://doi.org/10.3389/fvets.2021.750223openalex-snapshot
Evaluation of Potency and Duration of Immunity Elicited by a Multivalent FMD Vaccine for Use in South Africa
inferred← citeshttps://doi.org/10.3390/pathogens12060760openalex-snapshot
Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea
inferred← citeshttps://doi.org/10.3390/pathogens9030194openalex-snapshot
Evaluation of Quality Control Methods for Foot-And-Mouth Disease Vaccines by High-Performance Liquid Chromatography
inferred← citeshttps://doi.org/10.3390/v14081781openalex-snapshot
Assessment on Different Vaccine Formulation Parameters in the Protection against Heterologous Challenge with FMDV in Cattle
inferred← citeshttps://doi.org/10.3390/v16030457openalex-snapshot
Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor
inferred← citeshttps://doi.org/10.3390/v17121561openalex-snapshot
Characterization of a Virus Rescued from a Full-Length Infectious Clone Derived from the Type A Foot-and-Mouth Disease Virus Isolated in South Korea
inferred← citeshttps://doi.org/10.3390/v18050537openalex-snapshot
Evaluation of Antigen Productivity and Inactivation Kinetics of a Recombinant Foot-and-Mouth Disease SAT1 Vaccine Strain
inferred← citeshttps://doi.org/10.3390/vaccines11040815openalex-snapshot
Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A
inferred← citeshttps://doi.org/10.3390/vaccines11071156openalex-snapshot
Production of Foot-and-Mouth Disease Type O and A Vaccine Antigens on a Pilot Scale and Determination of Optimal Amount of Antigen for Monovalent Vaccines
inferred← citeshttps://doi.org/10.3390/vaccines12020185openalex-snapshot
Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics
inferred← citeshttps://doi.org/10.3390/vaccines12040367openalex-snapshot
Calcium Chloride as a Novel Stabilizer for Foot-and-Mouth Disease Virus and Its Application in the Vaccine Formulation
inferred← citeshttps://doi.org/10.3390/vaccines13030281openalex-snapshot
Foot-and-Mouth Disease Vaccines by Design; Production of Capsid-Modified Foot-and-Mouth Disease Viruses with Improved Cell Culture Growth
inferred← citeshttps://doi.org/10.3390/vaccines13050500openalex-snapshot
Single-Domain Antibodies That Specifically Recognize Intact Capsids of Multiple Foot-and-Mouth Disease Serotype O Strains
inferred← citeshttps://doi.org/10.3390/vaccines13070721openalex-snapshot
Simple and High-Throughput Quantification of Mono- and Bivalent Foot-and-Mouth Disease Virus Vaccine Antigens by Differential Scanning Fluorimetry
inferred← citeshttps://doi.org/10.3390/vaccines13121195openalex-snapshot
Construction of a Full-Length Infectious Clone Derived from Type O Foot-and-Mouth Disease Virus Isolated in South Korea for Vaccine Development with High Antigen Productivity
inferred← citeshttps://doi.org/10.3390/vaccines14030263openalex-snapshot
Evaluation of an Effective Intradermal Foot-and-Mouth Disease Vaccine for Early Protection
inferred← citeshttps://doi.org/10.3390/vaccines14050381openalex-snapshot
Evaluation of an In-House Developed Foot-and-Mouth Disease Virus SAT 3 Vaccine Strain Based on Antigen Productivity and Inactivation Kinetics for Commercial Feasibility
inferred← citeshttps://doi.org/10.3390/vaccines9030252openalex-snapshot
Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens
inferred← citeshttps://doi.org/10.3390/vaccines9040308openalex-snapshot
A Vaccine Strain of the A/ASIA/Sea-97 Lineage of Foot-and-Mouth Disease Virus with a Single Amino Acid Substitution in the P1 Region That Is Adapted to Suspension Culture Provides High Immunogenicity
inferred← citeshttps://doi.org/10.3390/vaccines9060586openalex-snapshot
Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs
inferred← citeshttps://doi.org/10.3390/vaccines9060620openalex-snapshot
Novel Capsid-Specific Single-Domain Antibodies with Broad Foot-and-Mouth Disease Strain Recognition Reveal Differences in Antigenicity of Virions, Empty Capsids, and Virus-Like Particles
inferred← citeshttps://doi.org/10.3390/vaccines9090996openalex-snapshot
Efficacy of SAT2 Foot-and-Mouth Disease Vaccines Formulated with Montanide ISA 206B and Quil-A Saponin Adjuvants
inferred← citeshttps://doi.org/10.35864/evmd.843095openalex-snapshot
Production of polyclonal antibodies against Turkey FMDV strains
inferred← citeshttps://doi.org/10.5455/jva.20130221053913openalex-snapshot
Studies on Growth Kinetics of the FMDV Serotype SAT-2 Egyptian Strain in Cell Culture
inferred← citeshttps://doi.org/10.7774/cevr.2020.9.2.97openalex-snapshot
Determination of non-structural protein level for Turkey foot-and-mouth disease vaccine antigens during in-process
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.